Biotech News

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

AtriCure (ATRC)AtriCureConference / presentation

MASON, Ohio --(BUSINESS WIRE)--May 27, 2026-- AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating

Open original release

Related news

AtriCure

AtriCure is a surgical device company focused on atrial fibrillation, left atrial appendage management, and cardiac ablation.

Recent company news

Stock data

Close
37.37 USD
Market cap
1.31B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States